How is the Artificial Organs And Bionic Implants Market Poised for Growth: Trends and Opportunities Through 2034
Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
How has the artificial organs and bionic implants market size evolved in recent years?
In recent years, the market size for artificial organs and bionic implants has seen robust growth. A rise from $45.02 billion in 2024 to $48.75 billion in 2025, representing a compound annual growth rate (CAGR) of 8.3%, is anticipated. The growth during the historical period is attributable to several factors such as an expanding elderly population, an escalation in organ failure instances, advancements in minimally invasive and robotic surgeries, a surge in the requirement for electronic bionic implants, and heightened healthcare spending.
What are the predictions for the artificial organs and bionic implants market size in the coming years?
In the coming years, the market for artificial organs and bionic implants is poised for robust expansion, eventually reaching a value of $66.35 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. This predicted growth in the forecast period can be credited to several factors such as the rise in health issues like diabetes, cardiovascular diseases, and kidney failure; the increasing incidence of organ transplants; a growing number of people on the waiting list for donors; the various benefits offered by these products; and a climbing number of transplant procedures. Prominent trends anticipated in the forecast period consist of progressions in 3D bioprinting technology, the incorporation of nanotechnology, the fabrication of intelligent implants, the use of AI to design and fine-tune artificial organs, and the invention of novel biocompatible materials.
Get your artificial organs and bionic implants market report here!
What key factors are fueling the growth of the artificial organs and bionic implants market?
The rise in organ transplant procedures is anticipated to fuel the growth of the artificial organs and bionic implants market in the future. Essentially, organ transplants involve the surgical placement of a healthy organ from a donor into a patient with a diseased, damaged, or dysfunctional organ. The surge in organ transplants is primarily due to the growing prevalence of chronic diseases and organ failures, combined with advancements in medical and surgical technology. Artificial organs and bionic implants support these processes by serving as temporary solutions, reducing wait times, enhancing patient outcomes, and providing alternatives when donor organs are unavailable. For example, the United Network for Organ Sharing, a US-based non-profit scientific and educational entity, reported that 42,887 organ transplants were carried out in the United States in 2022 as of January 2023, representing a 3.7% increase over 2021. Consequently, the increasing occurrence of organ transplants is catalyzing the growth of the artificial organs and bionic implants market.
How is the global artificial organs and bionic implants market divided into key segments?
The artificial organs and bionic implants market covered in this report is segmented –
1) By Product: Artificial Organs, Artificial Bionics
2) By Technology: Mechanical Bionics, Electronic Bionics
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Artificial Organs: Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Pancreas, Artificial Lungs
2) By Artificial Bionics: Bionic Limbs, Bionic Eyes, Bionic Ears, Neural Implants, Bionic Skin
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20487&type=smp
Who are the key firms paving the way for growth in the artificial organs and bionic implants market?
Major companies operating in the artificial organs and bionic implants market are Medtronic plc, Asahi Kasei Medical Co. Ltd., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Terumo Medical Corp., Edwards Lifesciences Corporation, Ottobock SE and Co. KGaA, Cochlear Limited, Ossur hf., Thoratec Corporation, Berlin Heart GmbH, Jarvik Heart Inc., SynCardia Systems LLC, BiVACOR Inc., Gambro AB, Pixium Vision, ALVI Labs, WillowWood Global LLC, Nano Retina Inc., Organovo Holdings Inc.
Which trends are expected to transform the artificial organs and bionic implants market?
Key players in the artificial organs and bionic implants realm are striving to innovate through the creation of cutting-edge solutions like brain implant technology systems. Such solutions serve to improve cognitive functions while addressing various neurological conditions. Brain implant technologies encompass devices that interact with the brain, with a view to monitor, stimulate, or adjust neural action for therapeutic reasons, neuroprosthetics, or research functions. As an illustration, in May 2023, Neuralink Corp., an American neurotechnology business, was granted approval by the Food and Drug Administration (FDA) to perform its initial human clinical tests of its brain implant technology. This technology’s objective is to enable severely paralysed individuals to communicate and operate external devices using only brain activity. This endorsement from the FDA is a critical breakthrough for the firm, which has encountered hurdles in the past, such as a previous rejection on safety grounds. The trial will assess the device’s efficacy in translating neural signals and broadcasting them via Bluetooth to manage computers and mobile gadgets, possibly aiding those suffering from conditions like amyotrophic lateral sclerosis (ALS).
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20487
What regions are contributing significantly to the growth of the artificial organs and bionic implants market?
North America was the largest region in the artificial organs and bionic implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organs and bionic implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Medical Bionic Implant/Artificial Organs Global Market Report 2025
Artificial Organ And Bionics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/artificial-organ-and-bionics-global-market-report
Spine Implants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/spine-implants-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
